Saeid Ghavami to Antiviral Agents
This is a "connection" page, showing publications Saeid Ghavami has written about Antiviral Agents.
Connection Strength
0.085
-
Emerging Advances of Nanotechnology in Drug and Vaccine Delivery against Viral Associated Respiratory Infectious Diseases (VARID). Int J Mol Sci. 2021 Jun 28; 22(13).
Score: 0.022
-
Autophagy, Unfolded Protein Response, and Neuropilin-1 Cross-Talk in SARS-CoV-2 Infection: What Can Be Learned from Other Coronaviruses. Int J Mol Sci. 2021 Jun 01; 22(11).
Score: 0.022
-
Lessons from SARS and MERS remind us of the possible therapeutic effects of implementing a siRNA strategy to target COVID-19: Shoot the messenger! J Cell Mol Med. 2020 09; 24(17):10267-10269.
Score: 0.021
-
FDA approved drugs with pharmacotherapeutic potential for SARS-CoV-2 (COVID-19) therapy. Drug Resist Updat. 2020 12; 53:100719.
Score: 0.021